An expert discusses how gene therapy represents a breakthrough treatment approach for BCG-unresponsive patients, offering ...

An expert discusses how patients with BCG-unresponsive non-muscle invasive bladder cancer (NMIBC) now have several ...

We’ll be back on Monday morning with more fresh content!

Managed Healthcare Executive gives C-suite executives in health plans and provider organizations news and strategies for ...

In this final video of a three-part video series, Joshua Fredell, Pharm.D., senior vice president at CVS Caremark and a ...

Sexual and gender minority individuals still face insurance denials and cost-sharing barriers when accessing pre-exposure ...

In this second part of a three-part of a video series, Kasey Raetz, Pharm.D., a PBMI Innovator, told MHE about leading the ...

The next step for the Rise For Health study researchers is to study the health benefits of frequent standing in older men and ...

Developed by Ionis Pharmaceuticals, Dawnzera is the first RNA-targeted medicine approved for HAE, designed to target plasma ...

Prefilled syringes of Imuldosa now have the lowest wholesaler acquisition cost among all branded ustekinumab biosimilars, ...

A new study finds Medicare beneficiaries are facing higher deductibles and cost-sharing requirements following changes ...

Tonmya is the first new fibromyalgia treatment approved by the FDA in more than 15 years, providing symptom relief for at ...